prostate-cancer

Documents about prostate-cancer

• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer#152419ClinicalTrials.gov
• pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer#152482ClinicalTrials.gov
• HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer#172317ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC#174870ClinicalTrials.gov
• Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer#184762ClinicalTrials.gov
• The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer#256843ClinicalTrials.gov
• Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)#303588ClinicalTrials.gov
• Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer#463726ClinicalTrials.gov
• Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer#640439ClinicalTrials.gov
• Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)#826210ClinicalTrials.gov
• ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer#829816ClinicalTrials.gov
• uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness#831865ClinicalTrials.gov
• Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis#832568ClinicalTrials.gov
• Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer#835758ClinicalTrials.gov
• Postoperative Prognosis Management Service Based mHealth for Prostate Cancer Patients#837937ClinicalTrials.gov
• Duke Urology Database and Specimen Bank#840683ClinicalTrials.gov
• Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI#845666ClinicalTrials.gov
• An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)#290975ClinicalTrials.gov
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer#839796ClinicalTrials.gov
• Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer#836899ClinicalTrials.gov
• Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis#843740ClinicalTrials.gov
• Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease#844058ClinicalTrials.gov
• Fertility After Prostate Brachytherapy#833710ClinicalTrials.gov
• Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer#825650ClinicalTrials.gov
• Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response#841517ClinicalTrials.gov
• Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe#843350ClinicalTrials.gov
• Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease#136398ClinicalTrials.gov
• Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer#141108ClinicalTrials.gov
• Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients#158126ClinicalTrials.gov
• Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy#253140ClinicalTrials.gov
• COAST Therapy in Advanced Solid Tumors and Prostate Cancer#414458ClinicalTrials.gov
• Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer#623520ClinicalTrials.gov
• Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer#802763ClinicalTrials.gov
• GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere#806762ClinicalTrials.gov
• Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer#807768ClinicalTrials.gov
• Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer#813496ClinicalTrials.gov
• Effect of ADT in Chinese Male With Prostate Cancer#827424ClinicalTrials.gov
• Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer#831770ClinicalTrials.gov
• Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer#834902ClinicalTrials.gov
• Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging#845551ClinicalTrials.gov
• Focal Prostate Radio-Frequency Ablation#804102ClinicalTrials.gov
• Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression#828253ClinicalTrials.gov
• Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study#831136ClinicalTrials.gov
• Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer#835992ClinicalTrials.gov
• Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer#834500ClinicalTrials.gov
• Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness#837823ClinicalTrials.gov
• Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer#845458ClinicalTrials.gov
• 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI#842797ClinicalTrials.gov
• Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer#844745ClinicalTrials.gov
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer#845003ClinicalTrials.gov